Announcements and Notices - [Issue of Shares under a General Mandate] SUBSCRIPTIONS OF NEW SHARES UNDER GENERAL MANDATE
Announcements and Notices - [Other - Business Update] VOLUNTARY ANNOUNCEMENT FIRST COHORT OF THE HEALTHY SUBJECTS DOSED IN A PHASE I CLINICAL TRIAL OF SM17 IN CHINA
Announcements and Notices - [Share Scheme] GRANT OF SHARE OPTIONS
Announcements and Notices - [Other - Business Update] VOLUNTARY ANNOUNCEMENT IND APPLICATION FOR SM03 (SUCIRASLIMAB) FOR THE TREATMENT OF ALZHEIMER'S DISEASE ACCEPTED BY NMPA CDE
Announcements and Notices - [Share Scheme] GRANT OF SHARE OPTIONS
Announcements and Notices - [Other - Business Update] VOLUNTARY ANNOUNCEMENT IND APPROVAL FOR SM17 BY NMPA
Announcements and Notices - [List of Directors and their Role and Function] LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS
Announcements and Notices - [Change in Directors or of Important Executive Functions or Responsibilities] CHANGE OF NON-EXECUTIVE DIRECTORS
Announcements and Notices - [Other - Business Update] VOLUNTARY ANNOUNCEMENT BLA ACCEPTED BY THE NMPA FOR SM03 (SUCIRASLIMAB) IN THE TREATMENT OF RHEUMATOID ARTHRITIS
Announcements and Notices - [Interim Results] INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED 30 JUNE 2023
Announcements and Notices - [Other - Business Update] VOLUNTARY ANNOUNCEMENT IND APPROVAL FOR SM17 BY NMPA
Announcements and Notices - [Date of Board Meeting] DATE OF BOARD MEETING
Announcements and Notices - [Results of AGM / Amendment of Constitutional Documents] POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON 12 JUNE 2023
Announcements and Notices - [Other - Business Update] VOLUNTARY ANNOUNCEMENT IND APPLICATION FOR SM17 ACCEPTED BY NMPA CDE
Announcements and Notices - [Other - Business Update] VOLUNTARY ANNOUNCEMENT IND APPLICATION FOR SM17 ACCEPTED BY NMPA CDE
Announcements and Notices - [Inside Information] INSIDE INFORMATION PHASE III CLINICAL STUDY OF SM03 (SUCIRASLIMAB) IN RHEUMATOID ARTHRITIS MEETS PRIMARY ENDPOINT
Announcements and Notices - [Notice of AGM / Closure of Books or Change of Book Closure Period] NOTICE OF 2023 ANNUAL GENERAL MEETING
Announcements and Notices - [Final Results / Dividend or Distribution / Closure of Books or Change of Book Closure Period / Change in Company Secretary] ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED 31 DECEMBER 2022; CHANGE IN USE OF PROCEEDS; AND CHANGE OF COMPANY SECRETARY
Announcements and Notices - [Terms of Reference of the Remuneration Committee] TERMS OF REFERENCE OF THE REMUNERATION COMMITTEE ADOPTED BY THE BOARD ON 20 MARCH, 2023
Announcements and Notices - [Date of Board Meeting] DATE OF BOARD MEETING